I’ve reported previously (see here) on Israel’s GlucoMe diabetes monitors. GlucoMe’s new Decision Support System (“DSS”) has just received the CE Mark. The DSS’s algorithm-based, clinical decision support software helps doctors monitor type 2 diabetes patients. https://www.glucome.com/about-us/news/GlucoMe-now-has-CE-Mark-for-Diabetes-Decision-Support-Technology

I reported previously (7th Jan) that Israel’s GlucoMe was shipping its glucose monitors to 200,000 Indian diabetics. Now Germany’s Merck KGaA is trialing GlucoMe’s monitors to help many of the 3.5 million Vietnamese suffering from diabetes – some 5.5% of … Continue reading →

I reported previously (see here) on Israel’s GlucoMe blood glucose monitors for diabetics.  Now, Apollo Sugar – the Indian national chain of 55 diabetes clinics – is to supply kits containing a GlucoMe monitor to each of its 200,000 diabetic … Continue reading →

I reported previously (Apr 16) on the “Digital Diabetes Clinic” developed by Israel’s GlucoMe. Yiftah Ben Aharon, CEO and co-founder of GlucoMe explains in an interview how GlucoMe helps the diabetic’s doctor make efficient use of the limited time available … Continue reading →

Israel’s GlucoMe has developed a “Digital Diabetes Clinic” that monitors diabetics and recommends treatment programs. The platform uses a smart glucose monitor, an insulin pen monitor, a mobile app and a cloud-based management system. It has completed trials and is … Continue reading →